Recalled H1N1 Vaccine Not Given Locally
Sanofi Pasteur, Inc has issued a voluntary recall of certain lots of Sanofi Pasteur H1N1 Pediatric Vaccine in pre-filled syringes after testing that found an antigen content level lower than required potency levels. The Webster Dictionary describes an antigen as a substance which provokes the formation of an antibody when it is introduced into another organism. Information received from the Ford-Iroquois Public Health Department states that the local agency has not had and does not currently have any of the recalled vaccine in their supply.
According to an alert put out this morning by the CDC (Centers for Disease Control and Prevention), the FDA (Food and Drug Administration) and the CDC are in agreement that the small decrease in antigen content is unlikely to result in a clinically significant reduction in immune response among persons who have received the vaccine. For this reason, says the report, there is no need to revaccinate persons who have received vaccine from these lots.
According to the report, all vaccines were thoroughly tested prior to release and shipping to determine that they met all manufacturer and FDA standards for purity, potency, and safety. The manufacturer is conducting a non-safety related voluntary recall of specific lots of the vaccine. The CDC and FDA have determined that there are no safety concerns for children who have received this vaccine.
For more information regarding the recall persons may call the CDC’s toll-free information line, 800-CDC-INFO (800-232-4636) TTY: (888)232-6348.
